Skip to main content

Hypertension as a Major Risk Factor in Diabetic Patients on Hemodialysis and CAPD

  • Conference paper
Diabetes and Hypertension
  • 108 Accesses

Abstract

The magnitude of the problem of hypertension in diabetic patients is illustrated by Fig. 1. In Type I diabetics with no proteinuria, the prevalence of hypertension is higher than in age- and sex-matched cohorts of the general population. Hypertension increases in progressively more advanced stages of nephropathy. Even more striking is the high prevalence of hypertension in nonproteinuric Type II diabetics, an observation which may be related — at least in part — to the possible role of insulin in raising blood pressure as recently discussed by many authors. The prevalence of hypertension increases with progressive severity of nephropathy such as occurs in Type I diabetics.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Hasslacher C, Stech W, Wahl P, Ritz E (1985) Blood pressure and metabolic control as risk factors for nephropathy in type I (insulin-dependent) diabetes. Diabetologia 28: 6

    Article  PubMed  CAS  Google Scholar 

  2. Hasslacher C, Terpstra J, Kunowski G, Gallasch G, Ritz E (1986) Metabolie control and blood pressure as risk factors for proliferative retinopathy in proteinuric type I diabetics. Transplant Proc XVIII: 1572–1573

    Google Scholar 

  3. Hasslacher C, Ritz E, Terpstra J, Gallasch G, Kunowski G, Rail C (1985) Natural history of nephropathy in type I diabetes. Relationship to metabolic control and blood pressure. Hypertension 7 [Suppl II): II-74-II-78

    Google Scholar 

  4. Hasslacher C, Wolfram M, Stech G, Wahl P, Ritz E (1987) Einfluß von Stoffwechseleinstellung und Blutdruck auf die Entwicklung der diabetischen Retinopathie beim Typ II Diabetes. Dtsch Med Wochenschr (in press)

    Google Scholar 

  5. Hasslacher C, Wahl P, Ritz E (1987) Similar risks of nephropathy in type I and type II diabetes (abstract). In: 20th Annual Meeting of the Society of Nephrologists, Washington DC

    Google Scholar 

  6. Ritz E, Hasslacher C, Tschöpe W, Koch M, Mann JFE (1987) Hypertension in diabetes mellitus. Contrib Nephrol 54: 77–86

    PubMed  CAS  Google Scholar 

  7. Mogensen CE (1976) Progression of nephropathy in long-term diabetics with proteinuria and effect of initial antihypertensive treatment. Scand J Clin Lab Invest 36: 384

    Article  Google Scholar 

  8. Anderson S, Rennke HG, Breuner B (1986) Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 77: 1993–2000

    Article  PubMed  CAS  Google Scholar 

  9. Reisch C, Mann J, Ritz E (1987) Konversionsenzymhemmer in der antihypertensiven Behand-lung niereninsuffizienter Patienten. Dtsch Med Wochenschr 112: 1249–1252

    Article  PubMed  CAS  Google Scholar 

  10. Challah S, Brunner FP, Wing AJ (1987) Evolution of the treatment of patients with diabetic nephropathy by renal replacement therapy in Europe over a decade. Data from the EDTA Registry. In: Mogensen CE (ed) Diabetes mellitus and the kidney. Nijhoff, (in press)

    Google Scholar 

  11. Strumpf C, Katz F, Wing AJ, Ritz E (1984) Cardiovascular risk factors and cardiovascular death in haemodialysed diabetic patients. Proc Eur Dial Transplant Assoc Eur Ren Assoc 21: 202–209

    Google Scholar 

  12. Ritz E, Strumpf C, Katz F, Wing AJ, Quellhorst E (1985) Hypertension and cardiovascular risk factors in hemodialyzed diabetic patients. Hypertension 7 [Suppl II]: II-118-II-124

    Google Scholar 

  13. Wing AJ, Brunner FP, Brynger H, Jacobs C, Kramer P, Selwood NH, Gretz N (1984) Car- diovascular-related causes of death and the fate of patients with renovascular disease. Contrib Nephrol 41: 306–311

    PubMed  CAS  Google Scholar 

  14. Hasslacher C, Rambausek M, Ritz E (1983) Genesis and management of hypertension in diabetic nephropathy. In: Keen H, Legrain M (eds) Prevention and treatment of diabetic nephropathy. MTP Press, Boston, pp 177–189

    Google Scholar 

  15. Chou LM, Beyer MM, Butt KM, Manis T, Friedman EA (1984) Hypertension jeopardizes diabetic patients following renal transplant. Trans Am Soc Artif Intern Org 30: 473–478

    CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Ritz, E., Hasslacher, C., Tschöpe, W. (1988). Hypertension as a Major Risk Factor in Diabetic Patients on Hemodialysis and CAPD. In: Gries, F.A., Weidmann, P. (eds) Diabetes and Hypertension. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73232-4_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-73232-4_15

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-18623-6

  • Online ISBN: 978-3-642-73232-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics